The US-based pharmaceutical Giant Eli Lilly has launched its diabetes and weight loss drug, India, India, standard standard management organization (CDSCO).
The pharmaceutical company has launched it by one dose of the bottle of marketing permits from CDSCO.
This very expected drug is the first treatment of obesity, overweight and type 2 diabetes.
“The double burden of obese and type 2 diabetes quickly develops a great public health challenge in India. Lily is committed to working with awareness and improving these disease prevention and management.
Mounjaro in India. Price, dose, etc.
MOUNJARO is a one-time weekly injection, which is available 2.5 mg of starting dose. One dose of 2.5 mg is worth 3,500 rubles, and the value of 5 mg is the value of 4,375 Rs.
MOUNJARO is a drug-based drug.
What is a Mindaron and how does it work?
For the fruitlessly, which is chemically known as Tirzepatide, mainly used by type 2 diabetes to control blood sugar levels. As novo Nordisk’s Ozempic, it also helps weight effective weight loss.
Tirzepatide works with two important hormones in the body: body, GIP and GLP-1.
“Technically, these Glucago, such as Peptide (GLP) -1 receptor agonists, promoting insulin release by the pancreas and also delay in catastrophic amount of food.
At the same time, influencing multiple body systems, Tirzepatide offers a powerful approach to both diabetes and weight management.
Refusal. This content, including advice, only gives general information. In no case is it replaced by a qualified medical opinion. For more information, always consult a specialist or your own doctor. NDTV is not responsible for this information.
